media – Page 515 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Fitbit unveils 8 applications for Ionic and Versa

A Fitbit official disclosed eight mobile health apps, including two focused on diabetes management and one on oncology care.
- Source: drugdu
- 943
- May 8, 2018
Company Insights Fitbit mHealth
Fitbit partners with Google digital health innovation

During the Fitbit Q1 earnings call, the company confirmed its focus on digital health regardless of the expected decline in sales numbers. Currently, Fitbit is focusing on its new alliance with Google, wherein the two companies will work together to speed up innovation in the digital health space to provide clear EHRs and precise patient data to help the clinicians.
- Source: Ddu
- 1,047
- May 8, 2018
Company Insights Market Views mHealth
Drugdu.com Launches Digital Marketing Strategy Solution for Pharmaceuticals and Medical Devices at CMEF Shanghai 2018

Drugdu.com presents their digital marketing strategy for the pharmaceutical and medical device industry and launches the Ddu Trade Accelerator to assist suppliers in expanding international business opportunities.
- Source: drugdu
- 2,509
- May 8, 2018
Exhibitions and Activities
New Oncology Clinical Collaboration between Nektar and Takeda to Evaluate Combination of NKTR-214, a CD122-biased Agonist, and TAK-659, a Dual SYK and FLT-3 Inhibitor, in Liquid and Solid Tumors

New collaboration to explore the potential clinical benefits of two novel and complementary immuno-oncology mechanisms
- Source: prnewswire
- 668
- May 8, 2018
multiple cancer TAK-659 Takeda
FDA Approves CAR T Therapy for Large B-Cell Lymphoma Developed at University of Pennsylvania

Nation’s first approved personalized cellular therapy now available for second indication
- Source: pennmedicine.org
- 528
- May 8, 2018
B-cell lymphoma FDA Kymriah
Privately-held Manipal increases bid for Fortis for INR 8358 Cr.

In a bid to sweeten its deal for Fortis Healthcare, Manipal Health Enterprises has proposed merging of both enterprises that pegs the value of the beleaguered Fortis at Rs. 8,358 crores. The buyout efforts of Manipal have been backed by US private equity firm TPG.
- Source: Ddu
- 535
- May 8, 2018
healthcare India Market Views
South-Indian states invite Midmark to set up unit

Midmark India, maker of medical equipment, is planning to set up its 15th center in the near future; the manufacturing unit is said to be set up in Andhra Pradesh or in Telengana.
- Source: Ddu
- 476
- May 8, 2018
Company Insights India medical device products
Health-Tech Startup Suki’s Voice Assistant Device for Doctors bags $20million

Suki, a California-based, health-tech startup founded by former Flipkart executive in 2017 is said to have raised a new round of capital of $15 million.
- Source: Ddu
- 699
- May 8, 2018
AI digital health Market Views
Study reveals combination of various genetic factors influence migraine risks

An investigation on 2 different theories about the hereditary ways in which migraines are found in family lines was conducted by a transatlantic team.
- Source: Ddu
- 595
- May 7, 2018
migraine Researches
PCORI funded $6.5 million to the California and San Francisco University.

The Patient-Centered Outcomes Researcher Institute (PCORI), a study to look at more effective ways to tackle uncontrolled hypertension using mHealth, was funded $6.5 million to the researchers of the University of California and San Francisco. The research includes whether the patients can care for themselves better at home through mHealth devices, compare to the doctors’ office.
- Source: Ddu - Jophy Joseph
- 549
- May 7, 2018
hypertension mHealth resea

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.